2014
DOI: 10.4155/tde.14.24
|View full text |Cite
|
Sign up to set email alerts
|

Cells As Delivery Vehicles for Cancer Therapeutics

Abstract: Cell-based therapeutics have advanced significantly over the past decade and are poised to become a major pillar of modern medicine. Three cell types in particular have been studied in detail for their ability to home to tumors and to deliver a variety of different payloads. Neural stem cells, mesenchymal stem cells and monocytes have each been shown to have great potential as future delivery systems for cancer therapy. A variety of other cell types have also been studied. These results demonstrate that the fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 99 publications
0
15
0
Order By: Relevance
“…The ability of certain types of stem and immune cells to target tumors, termed cytotherapeutics, allows their utilization as vectors to deliver several types of anticancer payloads [1,2]. Cells, as opposed to nanoparticles, which are driven by passive concentration gradients, have the ability to target and infiltrate the tumor interstitium by an active process.…”
Section: Background: Cells As Vectors For the Delivery Of Nanoparticlesmentioning
confidence: 99%
“…The ability of certain types of stem and immune cells to target tumors, termed cytotherapeutics, allows their utilization as vectors to deliver several types of anticancer payloads [1,2]. Cells, as opposed to nanoparticles, which are driven by passive concentration gradients, have the ability to target and infiltrate the tumor interstitium by an active process.…”
Section: Background: Cells As Vectors For the Delivery Of Nanoparticlesmentioning
confidence: 99%
“…The ability of certain types of stem and immune cells to target tumors allows their utilization as vectors to deliver several types of anti-cancer payloads (Fischbach et al 2013; Basel et al 2014). Cells have the ability to target and infiltrate the tumor interstitium by an active process (Fig.…”
Section: Cell Based Delivery Of Nanoparticlesmentioning
confidence: 99%
“…The primary goal of post-operative treatment is to reduce or eliminate tumor recurrence due to remaining malignant cells residing in the margin of the resection cavity. Targeted delivery approaches of chemotherapeutic drugs, such as cell-based vectorization, may result in improved outcomes since they can target and maintain elevated drug concentrations at the tumor site and prevent their spread into healthy tissue [1,2]. In contrast to nanoparticles, cells such as monocytes, Ma, and stem cells migrate to and infiltrate into tumors via an active process, despite stromal barriers and the elevated interstitial pressure present in most tumors.…”
Section: Introductionmentioning
confidence: 99%